A high-level delegation of US companies, organized by the US-China Business Council (USCBC), concluded a three-day visit to China’s Guangdong-Hong Kong-Macao Greater Bay Area (GBA) this week, underscoring growing confidence in the region’s economic potential. The visit, the largest of its kind to date, included executives from global giants like Procter & Gamble, Pfizer, and Cisco, spanning sectors from biomedicine to advanced manufacturing.
Innovation and Collaboration Take Center Stage
Sean Stein, president of the USCBC, emphasized that Guangdong’s transformation into a global innovation hub has reshaped opportunities for foreign investors. "The GBA is no longer just a manufacturing base—it’s a platform for co-creation," he said, highlighting the region’s cutting-edge policies and research ecosystems.
Long-Term Commitment to Shared Growth
Medtronic Greater China’s Cao Shan noted the company’s 37-year presence in the Chinese mainland, stating plans to deepen collaboration through Guangdong’s pilot innovation programs. Similarly, Westlake Corporation’s Pang Xiongying praised the region’s AI advancements, aiming to integrate local solutions into global operations.
A Gateway to Global Markets
With its blend of technological prowess and consumer market dynamism, the GBA continues to attract overseas businesses seeking to tap into Asia’s growth. The USCBC’s visit signals a broader trend of multinational firms aligning strategies with China’s development priorities, particularly in green tech and digital transformation.
